AXSOME THERAPEUTICS INC (AXSM) Stock Analyst Earnings Estimates
NASDAQ:AXSM - Nasdaq - US05464T1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.04M | 270.6M 440.77% | 385.693M 42.53% | 623.36M 61.62% | 991.24M 59.02% | 1.528B 54.15% | 2.074B 35.73% | 2.693B 29.85% | 3.154B 17.12% | 3.189B 1.11% | 3.547B 11.23% | |
| EBITDA YoY % growth | -174.9M -40.34% | -224.991M -28.64% | -272.604M -21.16% | -163.424M 40.05% | 84.033M 151.42% | 468.54M 457.57% | 756.46M 61.45% | 1.126B 48.85% | 1.255B 11.46% | 1.479B 17.85% | N/A | |
| EBIT YoY % growth | -179.3M -43.77% | -231.825M -29.29% | -280.562M -21.02% | -170.87M 39.10% | 86.486M 150.62% | 531.94M 515.06% | 939.89M 76.69% | 1.428B 51.93% | 1.792B 25.49% | 1.616B -9.82% | 1.753B 8.48% | |
| Operating Margin | -358.31% | -85.67% | -72.74% | -27.41% | 8.73% | 34.81% | 45.32% | 53.03% | 56.82% | 50.67% | 49.42% | |
| EPS YoY % growth | -4.57 -31.70% | -5.20 -13.79% | -5.99 -15.19% | -3.64 39.19% | 1.52 141.68% | 9.21 506.59% | 12.60 36.78% | 19.36 53.67% | 24.89 28.58% | 18.92 -24.00% | 20.64 9.10% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 36.44% | -0.57 62.71% | -0.48 61.02% | 0.19 119.28% | 0.89 204.60% | 1.58 374.42% |
| Revenue Q2Q % growth | 167.88M 60.25% | 191.17M 60.96% | 185.79M 52.96% | 230.54M 53.65% | 278.55M 65.92% | 326.62M 70.85% |
| EBITDA Q2Q % growth | -38.804M 31.61% | -28.274M 56.27% | 29.998M 152.49% | 74.491M 330.37% | 92.973M 339.60% | 111.28M 493.57% |
| EBIT Q2Q % growth | -40.475M 35.37% | -26.32M 63.76% | -25.534M 56.93% | 20.969M 157.11% | 54.149M 233.79% | 81.327M 409.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.97 41.92% | -1.12 | 0.15 | 13.71% |
| Q1 2025 Q2Q % growth | -1.22 15.28% | -1.35 | 0.13 | 9.80% |
| Q4 2024 Q2Q % growth | -1.54 25.96% | -1.04 | -0.50 | -48.67% |
| Q3 2024 Q2Q % growth | -1.34 -1.52% | -1.44 | 0.10 | 6.83% |
| Q2 2024 Q2Q % growth | -1.67 -8.44% | -1.36 | -0.31 | -22.89% |
| Q1 2024 Q2Q % growth | -1.44 -453.85% | -1.23 | -0.21 | -17.22% |
| Q4 2023 Q2Q % growth | -2.08 -47.52% | -1.19 | -0.89 | -74.11% |
| Q3 2023 Q2Q % growth | -1.32 -23.36% | -1.23 | -0.09 | -7.52% |
| Q2 2023 Q2Q % growth | -1.54 -45.28% | -1.25 | -0.29 | -23.51% |
| Q1 2023 Q2Q % growth | -0.26 74.76% | -1.06 | 0.80 | 75.39% |
| Q4 2022 Q2Q % growth | -1.41 -56.67% | -1.16 | -0.25 | -21.43% |
| Q3 2022 Q2Q % growth | -1.07 -15.05% | -1.10 | 0.03 | 2.80% |
| Q2 2022 Q2Q % growth | -1.06 -23.26% | -1.23 | 0.17 | 13.97% |
| Q1 2022 Q2Q % growth | -1.03 -32.05% | -1.02 | -0.01 | -0.75% |
| Q4 2021 Q2Q % growth | -0.90 -15.38% | -1.04 | 0.14 | 13.63% |
| Q3 2021 Q2Q % growth | -0.93 -60.34% | -0.97 | 0.04 | 4.06% |
| Q2 2021 Q2Q % growth | -0.86 -75.51% | -0.98 | 0.12 | 12.63% |
| Q1 2021 Q2Q % growth | -0.78 11.36% | -0.88 | 0.10 | 11.84% |
| Q4 2020 Q2Q % growth | -0.78 -9.86% | -0.77 | -0.01 | -0.90% |
| Q3 2020 Q2Q % growth | -0.58 -3.57% | -0.58 | 0.00 | 0.62% |
| Q2 2020 Q2Q % growth | -0.49 -19.51% | -0.63 | 0.14 | 22.07% |
| Q1 2020 Q2Q % growth | -0.88 -175.00% | -0.64 | -0.24 | -38.16% |
| Q4 2019 Q2Q % growth | -0.71 | -0.49 | -0.22 | -45.02% |
| Q3 2019 Q2Q % growth | -0.56 | -0.41 | -0.15 | -36.83% |
| Q2 2019 Q2Q % growth | -0.41 | -0.33 | -0.08 | -23.05% |
| Q1 2019 Q2Q % growth | -0.32 | -0.30 | -0.02 | -5.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 150.042M 72.13% | 141.6M | 8.442M | 5.96% |
| Q1 2025 Q2Q % growth | 121.463M 61.95% | 122.26M | -797K | -0.65% |
| Q4 2024 Q2Q % growth | 118.766M 66.03% | 120M | -1.234M | -1.03% |
| Q3 2024 Q2Q % growth | 104.762M 81.27% | 100.94M | 3.822M | 3.79% |
| Q2 2024 Q2Q % growth | 87.166M 89.42% | 88.66M | -1.494M | -1.69% |
| Q1 2024 Q2Q % growth | 74.999M -20.70% | 74.761M | 238K | 0.32% |
| Q4 2023 Q2Q % growth | 71.531M 193.52% | 68.915M | 2.616M | 3.80% |
| Q3 2023 Q2Q % growth | 57.794M 242.99% | 55.959M | 1.835M | 3.28% |
| Q2 2023 Q2Q % growth | 46.017M 421.73% | 41.753M | 4.264M | 10.21% |
| Q1 2023 Q2Q % growth | 94.576M | 26.591M | 67.985M | 255.67% |
| Q4 2022 Q2Q % growth | 24.37M | 22.195M | 2.175M | 9.80% |
| Q3 2022 Q2Q % growth | 16.85M | 16.968M | -118K | -0.70% |
| Q2 2022 Q2Q % growth | 8.82M | 6.418M | 2.402M | 37.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8.02% | -29.78% | 0% | -0.47% |
| Revenue | 0.87% | -1.24% | -0.59% | -1.03% |